๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effect of millimeter waves on natural killer cell activation

โœ Scribed by V.R. Makar; M.K. Logani; A. Bhanushali; M. Kataoka; M.C. Ziskin


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
194 KB
Volume
26
Category
Article
ISSN
0197-8462

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Effect of smoking on human natural kille
โœ Barbara Phillips; M. Ernest Marshall; Stephen Brown; John S. Thompson ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 374 KB ๐Ÿ‘ 2 views
Effect of millimeter wave irradiation on
โœ Mahendra K. Logani; Imre Szabo; Vera Makar; Ashok Bhanushali; Stan Alekseev; Mar ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 168 KB ๐Ÿ‘ 2 views

## Abstract One of the major side effects of chemotherapy in cancer treatment is that it can enhance tumor metastasis due to suppression of natural killer (NK) cell activity. The present study was undertaken to examine whether millimeter electromagnetic waves (MMWs) irradiation (42.2 GHz) can inhib

Effect of cyclophosphamide and 61.22 GHz
โœ V.R. Makar; M.K. Logani; A. Bhanushali; S.I. Alekseev; M.C. Ziskin ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 176 KB ๐Ÿ‘ 2 views

The present study was undertaken to investigate whether millimeter waves (MMWs) at 61.22 GHz can modulate the effect of cyclophosphamide (CPA), an anti-cancer drug, on the immune functions of mice. During the exposure each mouse's nose was placed in front of the center of the antenna aperture (1.5 ร‚

Adverse effects of intraportal chemother
โœ Rafique, Mohammad; Adachi, Wataru; Koike, Shoichiro; Kajikawa, Shoji; Yazawa, Ka ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 147 KB ๐Ÿ‘ 2 views

## Background: Adjuvant intraportal chemotherapy has been used with a view to prevent the development of metachronous hepatic metastases following curative resection for colorectal cancer. to evaluate the effects of this therapy on systemic antitumor immunological activity, 35 colorectal cancer pat